OPPI appoints Bhushan Akshikar as President Ruchika Sharma27 Sept 2024 12:25 PM ISTMumbai: The Organisation of Pharmaceutical Producers of India (OPPI), which represents the global research-based pharmaceutical companies in...
European Commission approves Janssen-Cilag Balversa for adult patients with metastatic urothelial carcinoma Ruchika Sharma25 Aug 2024 10:00 AM ISTBelgium: Janssen-Cilag International NV, a Johnson & Johnson company, has announced that the European Commission (EC) has approved...
JnJ submits application to USFDA for expansion of Pediatric indication for HIV-1 Therapy Prezcobix Ruchika Sharma5 Jun 2024 1:00 PM ISTTitusville: Johnson & Johnson has announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug...
Janssen seeks EMA marketing nod for Lazertinib plus Rybrevant for EGFR-Mutated Non Small Cell Lung Cancer Ruchika Sharma25 Dec 2023 3:30 PM ISTBelgium: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the submission of a marketing authorisation application...
Janssen seeks USFDA nod for Rybrevant plus chemotherapy for patients with EGFR-Mutated Non-Small Cell Lung Cancer who progressed on or after Osimertinib Ruchika Sharma23 Nov 2023 2:30 PM ISTRaritan: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the submission of a supplemental Biologics License ...
Guselkumab efficacious among patients of psoriasis with skin of color Dr. Kamal Kant Kohli24 Oct 2023 10:15 AM ISTUSA: Guselkumab exhibited fast and significant clearance in body and scalp psoriasis after one dose in patients with skin of color in a phase 3b...
Phase 3 Mariposa study evaluating Rybrevant plus Lazertinib meets primary endpoint in PFS in Non-Small Cell Lung Cancer: Janssen Ruchika Sharma2 Oct 2023 10:00 AM ISTRartan: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced positive topline results from the Phase 3 MARIPOSA study...
Janssen declares positive topline results from Phase 3 study evaluating RYBREVANT given with, without lazertinib combined with chemotherapy versus chemotherapy alone Ruchika Sharma9 Sept 2023 1:45 PM ISTNew Jersey: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced positive topline results from the three-arm Phase 3 ...
Janssen seeks USFDA full approval for Balversa for Urothelial Carcinoma Ruchika Sharma1 Sept 2023 12:30 PM ISTRaritan: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the submission of a supplemental New Drug Application...
European Commission nod to reduced dosing frequency for Janssen Tecvayli Ruchika Sharma20 Aug 2023 11:30 AM ISTTeclistamab is an off-the-shelf (or ready to use) bispecific antibody.
Johnson and Johnson gets USFDA accelerated nod for multiple myeloma drug Talvey Ruchika Sharma11 Aug 2023 11:29 AM ISTTALVEY is approved as a weekly or biweekly subcutaneous (SC) injection after an initial step-up phase, offering physicians the flexibility to...
Janssen seeks USFDA nod for single tablet combination therapy of Macitentan, Tadalafil for Pulmonary Arterial Hypertension Ruchika Sharma31 May 2023 3:30 PM ISTRaritan: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the submission of a New Drug Application (NDA) to the U.S. Food...
